2634 related articles for article (PubMed ID: 18490011)
1. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
[TBL] [Abstract][Full Text] [Related]
3. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
4. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
[TBL] [Abstract][Full Text] [Related]
6. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
[TBL] [Abstract][Full Text] [Related]
7. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
Sydow A; Mandelkow EM
Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
[TBL] [Abstract][Full Text] [Related]
8. Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model.
Lahiani-Cohen I; Lourbopoulos A; Haber E; Rozenstein-Tsalkovich L; Abramsky O; Grigoriadis N; Rosenmann H
J Neuropathol Exp Neurol; 2011 Jul; 70(7):610-21. PubMed ID: 21666497
[TBL] [Abstract][Full Text] [Related]
9. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
[TBL] [Abstract][Full Text] [Related]
10. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R
Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
[TBL] [Abstract][Full Text] [Related]
12. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of mouse model exhibiting neurofibrillary changes].
Takashima A
Rinsho Shinkeigaku; 2001 Dec; 41(12):1111-2. PubMed ID: 12235811
[TBL] [Abstract][Full Text] [Related]
14. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
15. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
16. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
[TBL] [Abstract][Full Text] [Related]
17. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
18. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
19. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
20. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein.
Rosenmann H; Grigoriadis N; Karussis D; Boimel M; Touloumi O; Ovadia H; Abramsky O
Arch Neurol; 2006 Oct; 63(10):1459-67. PubMed ID: 17030663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
